Compare Cigna Corp (CI) vs The Coca-Cola Co K (KO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs The Coca-Cola Co K — how do they compare? Cigna Corp trades at $272.21 (market cap $73.56B), while The Coca-Cola Co K trades at $86.63 (market cap $373.76B). The key difference: The Coca-Cola Co K is far larger — about 5.1× Cigna Corp's market cap, and The Coca-Cola Co K pays the higher dividend (2.44%). Which is the better fit depends on your goals.
| CI | KO | |
|---|---|---|
Market Cap | $73.56B | $373.76B |
Sector | Health | Consumer Staples |
52-Week High | $311.00 | $89.08 |
52-Week Low | $244.41 | $65.67 |
Enterprise Value | $98.27B | $400.93B |
Dividend Yield | 2.24% | 2.44% |
Volume | — | 14,630,257 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
Coca-Cola (KO) trades at $86.79, down slightly by 0.3% on the day, with a bullish technical signal and strong fundamental performance. The stock exhibits robust profitability with a net income margin of 28.56% and has beaten earnings estimates for the last three quarters. Recent news highlights institutional buying and stable demand trends, while the company maintains a 64-year dividend growth streak, reinforcing its defensive appeal.
The outlook for KO remains positive, supported by consistent earnings beats, a high analyst buy rating (60%), and a consensus price target of $95.83 implying ~10% upside. Key risks include regional demand divergence and high debt levels, but the stock's quality fundamentals and dividend reliability offer a compelling case for long-term investors amid market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About The Coca-Cola Co K
The Coca-Cola Company manufactures, markets, and distributes soft drink concentrates and syrups. The Company also distributes and markets juice and juice-drink products. Coca-Cola distributes its products to retailers and wholesalers in the United States and internationally.
Read more on KO →
